Men with colorectal cancer are not routinely offered information and treatment for erectile dysfunction, according to an Oncology Nurse Advisor report. Professor Sue Wilson of the Cancer and Chronic ...

Read more about the under-prescription of first-line treatments for erectile dysfunction in patients with prostate cancer.

Results from a phase 3 clinical trial, recently published in The Lancet Oncology, present a significant breakthrough in the field of prostate cancer surgery. The NeuroSAFE technique, a novel approach ...

The results of the NeuroSAFE PROOF trial, presented at the 2025 European Association of Urology (EAU) Congress in Madrid and published in TheLancet Oncology, raise the prospect of major quality of ...

There were an estimated 1,926,136 cases of CRC in 2022, marking CRC as one of the most widely encountered cancer types. 1 ICI-based neoadjuvant therapy has shown good therapeutic potential in the past ...

Testosterone testing and treatment have increased significantly over the past 2 decades, yet clinical practices remain inconsistent. 1,2 Despite rising awareness and prescription trends, up to 25% of ...

The procedure allows doctors to check and see if they’ve removed all cancer cells while surgery is in progress If they have, they can spare the prostate nerves that are responsible for producing ...